Status: Recruiting
Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
This study will evaluate the safety, PK, and efficacy of AT 1501 in patients undergoing kidney transplantation.
Participants needed: 48
Trial details
Phase: Phase 1, Phase 2Age: 18-100Biological sex: AllType: InterventionalSponsor: Eledon PharmaceuticalsUpdated: Jun 29, 2025Locations: 9
Eligibility criteria
Male or female ≥ 18 years of age [+2]
Induction therapy, other than study assigned rATG, planned as part of initial im... [+12]